ZP
DBTX

Zimmer Partners’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Zimmer Partners’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,000
Closed -$430K – 206
2021
Q2 		$430K Hold
50,000
– – 0.01% 161
2021
Q1 		$568K Buy
+50,000
New +$785K 0.01% 152

Other funds holding DBTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return

Zimmer Partners's DBTX Position: Q3 2021 in Review

Zimmer Partners sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2021, closing a stake of 50,000 shares — an estimated $430K sold.

Zimmer Partners first reported a position in DBTX in Q1 2021 and held it in 2 quarters. The position peaked at $568K in Q1 2021. 36 funds tracked by Wall St. Rank hold DBTX as of Q3 2021.

  • Zimmer Partners reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Zimmer Partners sold 50,000 Decibel Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $430K.
  • Zimmer Partners first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Zimmer Partners's Decibel Therapeutics, Inc. Common Stock position peaked at $568K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Zimmer Partners's 13F filing for Q3 2021, filed 15 Nov 2021.